We focus on peer-reviewed scientific studies and "studies of studies" for our information on the benefits and harms of controlled substances. However, we also believe it is important to not focus on any one study, and instead try to undertand scientific consensus as it build. We also try to understand and account for confirmation bias...the tendancy we all have to give more weight to information that supports our pre-existing beliefs. We also review critical analysis of controlled substances and opinion pieces, and weigh them accordinly.
An overview of the symptoms of serotonin syndrome for non medical professionals. Serotonin syndrome is a potentially lethal condition, which requires immediate medical care. Non-medical professionals are not qualified to diagnosis serotonin syndrome, but knowing the warning signs may help accelerate a trip to the emergency room.Read More
MDMA cleared for Phase III Study in US re PTSD
The FDA cleared MDMA for a Phase III Study under the classification of a potential "Breakthrough Therapy". However, the study has not yet been funded. MAPS is currently raising money for the potential study.
Press Release: MAPS Press Release
Drug harms in the UK: a multicriteria decision analysis
Background Proper assessment of the harms caused by the misuse of drugs can inform policy makers in health, policing, and social care. We aimed to apply multicriteria decision analysis (MCDA) modelling to a range of drug harms in the UK.
Method Members of the Independent Scientific Committee on Drugs, including two invited specialists, met in a 1-day interactive workshop to score 20 drugs on 16 criteria: nine related to the harms that a drug produces in the individual and seven to the harms to others. Drugs were scored out of 100 points, and the criteria were weighted to indicate their relative importance.Read More